Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04994457 · ClinicalTrials.gov registry record
Patient Performance on Virtual Reality Visual Field Devices as Compared to Standard of Care
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 287
- Enrollment target
NCT04994457: Completed study, sponsored by University of Miami.
NCT04994457 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 287 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04994457 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 287 participants
- Enrollment target
Study Summary
The purpose of this research is to study the effectiveness and patient experience when measuring visual fields using virtual reality goggles.
Primary Outcome
Sensitivity of VRVF will be determined by comparing Hodapp Anderson Parrish (HAP) Scores, which assess the severity of visual field defects, to those of SAP
Interventions
- DEVICE Virtual Reality Visual Field
- DIAGNOSTIC_TEST Standard Automated Perimetry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 287 participants |
| Start Date | 2021-10-30 |
| Est. Completion | 2024-06-21 |
What the finished NCT04994457 record still lists
NCT04994457 is an observational study that tracks outcomes without assigning an intervention. The registered 287 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Virtual Reality Visual Field is the first listed.
NCT04994457 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04994457 about?
NCT04994457 is a clinical study titled "Patient Performance on Virtual Reality Visual Field Devices as Compared to Standard of Care". The purpose of this research is to study the effectiveness and patient experience when measuring visual fields using virtual reality goggles.
What is the current status of trial NCT04994457?
This trial is currently completed. The enrollment target is 287 participants. The study started on 2021-10-30. Estimated completion is 2024-06-21.
What interventions are being tested in trial NCT04994457?
The interventions under investigation include: Virtual Reality Visual Field (DEVICE), Standard Automated Perimetry (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04994457?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03094429 · 287 participants · Phase 2
An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults
- NCT06385080 · 287 participants · Phase 1
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- NCT06919224 · 287 participants · NA
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI